Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- Product Overview:
Cayman’s Protein A/G Coated Plate Immunoprecipitation (IP) Kit provides a convenient method for the capture and concentration of target proteins from cell lysates, serum, and hybridoma culture media, as well as recombinant protein or recombinant antibody media, in a 96-well plate format. Following elution of the captured proteins from Protein A/G Coated 96-well strip plate, SDS-PAGE, Western blot, and mass spectrometry can be used for further analysis. This kit provides the following advantages over traditional tube- or resin-based IP methods: 1.The 96-well plate format allows for higher throughput by allowing the user to work with up to 96 samples 2.Much less time spent washing, as wells can be washed via multichannel pipette in seconds versus the minutes required for tube washes 3. No accidental transfer of resin beads between washes or during sample loading
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.